BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29493105)

  • 1. Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial.
    Jones RB; Alderete TL; Martin AA; Geary BA; Hwang DH; Palmer SL; Goran MI
    Pediatr Obes; 2018 Nov; 13(11):705-714. PubMed ID: 29493105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.
    Solito A; Bozzi Cionci N; Calgaro M; Caputo M; Vannini L; Hasballa I; Archero F; Giglione E; Ricotti R; Walker GE; Petri A; Agosti E; Bellomo G; Aimaretti G; Bona G; Bellone S; Amoruso A; Pane M; Di Gioia D; Vitulo N; Prodam F
    Clin Nutr; 2021 Jul; 40(7):4585-4594. PubMed ID: 34229263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
    Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
    Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
    Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
    PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial.
    Halkjaer SI; Nilas L; Carlsen EM; Cortes D; Halldórsson TI; Olsen SF; Pedersen AE; Krogfelt KA; Petersen AM
    Trials; 2016 Oct; 17(1):491. PubMed ID: 27724923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
    Gomes AC; Hoffmann C; Mota JF
    Eur J Nutr; 2020 Jun; 59(4):1751-1762. PubMed ID: 31250099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.
    Stenman LK; Lehtinen MJ; Meland N; Christensen JE; Yeung N; Saarinen MT; Courtney M; Burcelin R; Lähdeaho ML; Linros J; Apter D; Scheinin M; Kloster Smerud H; Rissanen A; Lahtinen S
    EBioMedicine; 2016 Nov; 13():190-200. PubMed ID: 27810310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Multispecies Synbiotic Supplementation on Body Composition, Antioxidant Status, and Gut Microbiomes in Overweight and Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.
    Oraphruek P; Chusak C; Ngamukote S; Sawaswong V; Chanchaem P; Payungporn S; Suantawee T; Adisakwattana S
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Stool Microbiome in Hispanic Preschool Children by Weight Status and Time.
    Hollister EB; Foster BA; Dahdouli M; Ramirez J; Lai Z
    Child Obes; 2018; 14(2):122-130. PubMed ID: 29028448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-Week Exercise Training With Dietary Restriction Improves Central Hemodynamics Associated With Altered Gut Microbiota in Adolescents With Obesity.
    Huang J; Liao J; Fang Y; Deng H; Yin H; Shen B; Hu M
    Front Endocrinol (Lausanne); 2020; 11():569085. PubMed ID: 33365012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.
    Alisi A; Bedogni G; Baviera G; Giorgio V; Porro E; Paris C; Giammaria P; Reali L; Anania F; Nobili V
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1276-85. PubMed ID: 24738701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.
    Dhiman RK; Rana B; Agrawal S; Garg A; Chopra M; Thumburu KK; Khattri A; Malhotra S; Duseja A; Chawla YK
    Gastroenterology; 2014 Dec; 147(6):1327-37.e3. PubMed ID: 25450083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.
    Nicolucci AC; Hume MP; Martínez I; Mayengbam S; Walter J; Reimer RA
    Gastroenterology; 2017 Sep; 153(3):711-722. PubMed ID: 28596023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
    Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
    Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
    BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial.
    Pastor-Villaescusa B; Plaza-Díaz J; Egea-Zorrilla A; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
    Biomed Pharmacother; 2021 Feb; 134():111117. PubMed ID: 33360047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children.
    Sanchis-Chordà J; Del Pulgar EMG; Carrasco-Luna J; Benítez-Páez A; Sanz Y; Codoñer-Franch P
    Eur J Nutr; 2019 Oct; 58(7):2789-2800. PubMed ID: 30251018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
    Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
    Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.